Non-Small Cell Lung Cancer with Malignant Pleural Effusion May Require Primary Tumor Radiotherapy in Addition to Drug Treatment.

Qingsong Li,Cheng Hu,Shengfa Su,Zhu Ma,Yichao Geng,Yinxiang Hu,Huiqin Li,Bing Lu

Cancer management and research（2022）

引用 0|浏览5

暂无评分

摘要

For MPE-C-NSCLC, the response of systemic drug treatment plays a crucial role in survival outcomes, and we also should pay attention to primary tumour radiotherapy in addition to systematic drug treatment.

查看译文

关键词

controlled malignant pleural effusion,non-small cell lung cancer,overall survival,prognosis,radiotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要